ThermoGenesis names Engle CEO - Sacramento Business Journal:

http://laptopupgrader.com/cat-presario-v4000-c1018/
Matthew Plavan, who has served as the Rancho Cordova company’s (Nasdaq: KOOL) interim CEO sincr December, has become the chief operatinv officer. He will retain his titles of executive vice presideng and chief financial officer ofthe company, whicyh makes devices for storing and processing stem cell and blood products. “Mel has served as presidenr and CEO of three healtbcare companies, as well as having extensive management experience in operations, sales and international markeyt development with both large and smalkl device and pharmaceutical organizations,” said Patrick McEnany, director and chairma of the company’s governance and nominating in a news release.
“After conducting an extensive searchu and interviewing a number ofexcellenf candidates, it was clear to the boarc that Mel’s wide-ranging health care industry experience made him a grea fit for ThermoGenesis.” Engle’s last job was CEO of , a lase technology company. Before that he spent six years as presidengt and CEOof , a $600 milliom specialty pharmaceutical company affiliated with Merck KGaA. Prio to that he was chairman, president and CEO of , a publicly traded medical device company.
Engle’sx has also worked as regional directort in North America for and held senior management position s with He is a member of the boar d of directorsof (OTCBB: OXBO), formerlhy known as , which is developing oxygen-deliver y therapies. He has a bachelor’s degree in accountinv from the University of Colorado anda master’se degree in business administration with a specialtyu in finance from the University of Southern “I am excited to be joininvg ThermoGenesis, particularly at a time of heightenesd interest in and growing awareness of the therapeutic value of stem Engle said in the news release.
“ThermoGenesiss possesses a strong technology base with a dedicate d and knowledgeable groupof employees. It is well positioned to capitalizre on the growing stemcell market. ThermoGenesia has a track record of producrt innovation and is on the cusp of realizing an increaseed market presence with its current andnew “I appreciate the support of our board and employeexs over the past several months and look forward to workinv with Mel on a further implementatiohn of our turnaround strategy,” Plavan said in the news release.